BioNTech SE (BNTX) Current Assets (2018 - 2025)
BioNTech SE (BNTX) posted Current Assets of $18.8 billion for Q4 2025, up 1.56% sequentially from $18.5 billion in Q3 2025, and down 6.46% YoY from $20.1 billion in Q4 2024.
BioNTech SE (BNTX) Current Assets (2018 - 2025) Analysis & Trends
BioNTech SE has reported Current Assets for 8 years, with the latest figure at $18.8 billion in Q4 2025.
- Quarterly Current Assets fell 6.46% year-over-year to $18.8 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.8 billion (down 6.46% YoY) and the FY2025 annual result came in at $18.2 billion, down 9.21% from the prior year.
- Current Assets grew to $18.8 billion in Q4 2025 per BNTX's latest filing, from $18.5 billion in the prior quarter.
- Over five years, Current Assets peaked at $22.4 billion in Q4 2022 and troughed at $4.3 billion in Q1 2021.
- A 5-year average of $18.5 billion and a median of $20.0 billion in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2021 and 2025: Current Assets surged 1385.59% in 2021, then retreated 17.21% in 2025.
- Over 5 years, Current Assets stood at $17.2 billion in 2021, then grew by 29.72% to $22.4 billion in 2022, then slipped by 6.06% to $21.0 billion in 2023, then dropped by 4.36% to $20.1 billion in 2024, then retreated by 6.46% to $18.8 billion in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $18.8 billion, $18.5 billion, and $18.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 18.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.80 Bn |
| Sep 30, 2025 | 18.51 Bn |
| Jun 30, 2025 | 18.03 Bn |
| Mar 31, 2025 | 16.44 Bn |
| Dec 31, 2024 | 20.09 Bn |
| Sep 30, 2024 | 20.30 Bn |
| Jun 30, 2024 | 19.69 Bn |
| Mar 31, 2024 | 19.85 Bn |
| Dec 31, 2023 | 21.01 Bn |
| Sep 30, 2023 | 20.41 Bn |
| Jun 30, 2023 | 20.92 Bn |
| Mar 31, 2023 | 21.56 Bn |
| Dec 31, 2022 | 22.37 Bn |
| Sep 30, 2022 | 21.44 Bn |
| Jun 30, 2022 | 21.56 Bn |
| Mar 31, 2022 | 21.85 Bn |
| Dec 31, 2021 | 17.24 Bn |
| Sep 30, 2021 | 15.98 Bn |
| Jun 30, 2021 | 10.16 Bn |
| Mar 31, 2021 | 4.27 Bn |